Technology

The exclusive technology platforms under development at Diazamed utilize a natural therapeutic agent that has been integrated onto the surfaces of medical devices. These coatings create surface passivation and subsequent prevention of detrimental biofouling processes directly at the blood-contacting interface of the device. These platform materials and coatings for medical devices have several advantageous features, including:

• Controllable short- and long-term durations
• Prevention of platelet activation and reductions in surface thrombosis
• Reduction in rates of infection and inflammation
• Improvements in natural wound healing processes
• Synthetic surfaces are safe and non-cytotoxic as measured by ISO 10993 standards
• Materials can be integrated into current device manufacturing processes such as extrusion, dip coating, and spray coating
• Materials are suitable for handling and storage in routine clinical applications